TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
A clinical trial evaluating TQB3616 capsules versus placebo in the treatment of
dedifferentiated liposarcoma. Divided into 2 stages, the second stage, a total of 118
subjects are planned to be enrolled.